Sources | Names Used |
---|---|
CTRPv2 | tretinoin:navitoclax (4:1 mol/mol) |
PharmacoGx | tretinoin:navitoclax (4:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | SMARCA2 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
mRNA | PDIK1L | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
mRNA | CHODL | CTRPv2 | pan-cancer | AAC | 0.1 | 0.003 |
mRNA | RAB11FIP3 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
mRNA | NT5C1B | CTRPv2 | pan-cancer | AAC | 0.1 | 0.003 |
mRNA | ST6GAL2 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
mRNA | APEX1 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
mRNA | HOOK1 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.003 |
mRNA | RP11-468E2.2 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
mRNA | DMRTA1 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |